164 related articles for article (PubMed ID: 37924640)
1. 17β-hydroxysteroid dehydrogenase type 1 improves survival in serous epithelial ovarian tumors.
Pedernera E; Morales-Vásquez F; Gómora MJ; Almaraz MA; Mena E; Pérez-Montiel D; Rendon E; López-Basave H; Maldonado-Cubas J; Méndez C
Endocr Connect; 2023 Dec; 12(12):. PubMed ID: 37924640
[TBL] [Abstract][Full Text] [Related]
2. An assessment of the multifactorial profile of steroid-metabolizing enzymes and steroid receptors in the eutopic endometrium during moderate to severe ovarian endometriosis.
Anupa G; Sharma JB; Roy KK; Sengupta J; Ghosh D
Reprod Biol Endocrinol; 2019 Dec; 17(1):111. PubMed ID: 31878927
[TBL] [Abstract][Full Text] [Related]
3. Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.
Chanplakorn N; Chanplakorn P; Suzuki T; Ono K; Chan MS; Miki Y; Saji S; Ueno T; Toi M; Sasano H
Breast Cancer Res Treat; 2010 Apr; 120(3):639-48. PubMed ID: 20151319
[TBL] [Abstract][Full Text] [Related]
4. Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.
Aka JA; Calvo EL; Lin SX
Mol Cell Endocrinol; 2017 Jan; 439():175-186. PubMed ID: 27544780
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors.
Calvillo-Robledo A; Pedernera E; Morales-Vásquez F; Pérez-Montiel D; Gómora MJ; Almaraz MÁ; de Alba Graue PG; Rendón E; López-Basave HN; Quintanar-Stephano A; Méndez C
J Ovarian Res; 2021 Jul; 14(1):98. PubMed ID: 34321053
[TBL] [Abstract][Full Text] [Related]
6. Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition.
Sang X; Han H; Li T; Lin SX
J Steroid Biochem Mol Biol; 2019 Oct; 193():105411. PubMed ID: 31207361
[TBL] [Abstract][Full Text] [Related]
7. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.
Aka JA; Zerradi M; Houle F; Huot J; Lin SX
Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413
[TBL] [Abstract][Full Text] [Related]
8. Substrate inhibition of 17β-HSD1 in living cells and regulation of 17β-HSD7 by 17β-HSD1 knockdown.
Han H; Thériault JF; Chen G; Lin SX
J Steroid Biochem Mol Biol; 2017 Sep; 172():36-45. PubMed ID: 28554725
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 16β-derivatives of 3-(2-bromoethyl)-estra-1,3,5(10)-trien-17β-ol as inhibitors of 17β-HSD1 and/or steroid sulfatase for the treatment of estrogen-dependent diseases.
Lespérance M; Roy J; Djiemeny Ngueta A; Maltais R; Poirier D
Steroids; 2021 Aug; 172():108856. PubMed ID: 33945801
[TBL] [Abstract][Full Text] [Related]
10. High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer.
Miyoshi Y; Ando A; Hasegawa S; Ishitobi M; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2288-93. PubMed ID: 12796397
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the mRNA expression of StAR and steroidogenic enzymes in zebrafish ovarian follicles.
Ings JS; Van Der Kraak GJ
Mol Reprod Dev; 2006 Aug; 73(8):943-54. PubMed ID: 16700073
[TBL] [Abstract][Full Text] [Related]
12. Molecular framework of steroid/retinoid discrimination in 17beta-hydroxysteroid dehydrogenase type 1 and photoreceptor-associated retinol dehydrogenase.
Haller F; Moman E; Hartmann RW; Adamski J; Mindnich R
J Mol Biol; 2010 Jun; 399(2):255-67. PubMed ID: 20382160
[TBL] [Abstract][Full Text] [Related]
13. siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo.
Li F; Zhu Z; Xue M; He W; Zhang T; Feng L; Lin S
Drug Des Devel Ther; 2019; 13():757-766. PubMed ID: 30863015
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase isozymes in human ovarian surface epithelium and epithelial ovarian carcinoma.
Motohara K; Tashiro H; Taura Y; Ohba T; Katabuchi H
Med Mol Morphol; 2010 Dec; 43(4):197-203. PubMed ID: 21267695
[TBL] [Abstract][Full Text] [Related]
15. New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitory activity and selectivity.
Bey E; Marchais-Oberwinkler S; Negri M; Kruchten P; Oster A; Klein T; Spadaro A; Werth R; Frotscher M; Birk B; Hartmann RW
J Med Chem; 2009 Nov; 52(21):6724-43. PubMed ID: 19831396
[TBL] [Abstract][Full Text] [Related]
16. Sex steroids and leptin regulate 11beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: Sex specificities.
Dieudonné MN; Sammari A; Dos Santos E; Leneveu MC; Giudicelli Y; Pecquery R
J Steroid Biochem Mol Biol; 2006 Jun; 99(4-5):189-96. PubMed ID: 16621515
[TBL] [Abstract][Full Text] [Related]
17. An irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 inhibits estradiol synthesis in human endometriosis lesions and induces regression of the non-human primate endometriosis.
Poirier D; Nyachieo A; Romano A; Roy J; Maltais R; Chai D; Delvoux B; Tomassetti C; Vanhie A
J Steroid Biochem Mol Biol; 2022 Sep; 222():106136. PubMed ID: 35691460
[TBL] [Abstract][Full Text] [Related]
18. Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells.
Zhang CY; Wang WQ; Chen J; Lin SX
J Steroid Biochem Mol Biol; 2015 Jun; 150():24-34. PubMed ID: 25257817
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.
Frotscher M; Ziegler E; Marchais-Oberwinkler S; Kruchten P; Neugebauer A; Fetzer L; Scherer C; Müller-Vieira U; Messinger J; Thole H; Hartmann RW
J Med Chem; 2008 Apr; 51(7):2158-69. PubMed ID: 18324762
[TBL] [Abstract][Full Text] [Related]
20. 17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.
Aka JA; Mazumdar M; Chen CQ; Poirier D; Lin SX
Mol Endocrinol; 2010 Apr; 24(4):832-45. PubMed ID: 20172961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
